Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: AIDS. 2012 Mar 13;26(5):599–607. doi: 10.1097/QAD.0b013e32834fa121

Fig. 1. Aspartate aminotransferase-to-platelet ratio index data for 153 hepatitis C virus/HIV-co-infected women on HAART who died and had at least two fibrosis marker assessments (aspartate aminotransferase-to-platelet ratio index or FIB-4) available within 5 years of their death.

Fig. 1

The figure depicts aspartate aminotransferase-to-platelet ratio index (APRI) data from the last available fibrosis marker assessment up to 5 years before death for 133 nonliver-related (a: upper panel) and for 20 liver-related (b: lower panel) deaths. The solid, black curve is the regression line. APRI is depicted on a log-scale with cut-off lines for low (<0.5) and high (>1.5) values.